Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_PLEURA,Wald ratio,1,2.08 [1.26-3.42],0.0040886437413336,cis
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,Wald ratio,1,5.23 [1.63-16.7],0.00528300369077478,cis
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,Wald ratio,1,0.33 [0.15-0.73],0.00665731120059903,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_AF,Wald ratio,1,1.76 [1.17-2.66],0.00717917887112907,cis
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_PLEUREFFUSION,Wald ratio,1,3.4 [1.38-8.37],0.00783251697708535,cis
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,Wald ratio,1,0.37 [0.17-0.79],0.010087999569546,cis
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,Wald ratio,1,430.2 [3.53-52433.05],0.0133361900020402,cis
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,Wald ratio,1,4.5 [1.12-18],0.033505095886368,cis
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,Wald ratio,1,0.6 [0.37-0.98],0.0403768187224846,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,Wald ratio,1,6.66 [1.07-41.38],0.0418010434905176,cis
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_DIAHER,Wald ratio,1,0.56 [0.32-0.98],0.0424362936377653,cis
SCG2,Secretogranin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_PURPURA_AND3_OTHER_HAEMORRHAGIC,Wald ratio,1,2.65 [1.02-6.91],0.0456261204574926,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_ANGINA,Wald ratio,1,1.44 [0.99-2.1],0.0585930801363054,cis
SCG2,Secretogranin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERANAEMIA,Wald ratio,1,1.58 [0.97-2.57],0.0666525670417877,cis
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Wald ratio,1,1.35 [0.97-1.9],0.0772811433089913,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,Wald ratio,1,0.18 [0.03-1.21],0.0780322436434547,cis
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,Wald ratio,1,1.41 [0.95-2.1],0.0855448836794134,cis
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,Wald ratio,1,0.37 [0.11-1.18],0.091478086353798,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_RHEUVALV,Wald ratio,1,6.76 [0.72-63.85],0.0953548195830653,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_ARTOTH,Wald ratio,1,0.37 [0.12-1.19],0.0953673089196927,cis
SCG2,Secretogranin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Wald ratio,1,0.64 [0.38-1.08],0.0965976805815715,cis
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_OESSTODUO,Wald ratio,1,0.79 [0.6-1.04],0.09717717737832,cis
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,Wald ratio,1,0.75 [0.52-1.06],0.103457926553801,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_IHD,Wald ratio,1,1.28 [0.95-1.72],0.104735939220091,cis
SCG2,Secretogranin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_BLOOD_IMMUN,Wald ratio,1,1.34 [0.94-1.91],0.107242386434488,cis
SCG2,Secretogranin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Wald ratio,1,0.62 [0.34-1.13],0.119736712877555,cis
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,Wald ratio,1,0.47 [0.19-1.22],0.121415652136506,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_PULMOTHHD,Wald ratio,1,0.29 [0.06-1.39],0.122777645310747,cis
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,Wald ratio,1,0.12 [0.01-2.1],0.146339335375415,cis
SCG2,Secretogranin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Wald ratio,1,1.3 [0.91-1.86],0.153987693833359,cis
SCG2,Secretogranin-2,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_FUNGAL_IMPL,Wald ratio,1,2.59 [0.69-9.64],0.15713498552477,cis
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_LOWERINF,Wald ratio,1,1.35 [0.88-2.06],0.164453809091573,cis
SCG2,Secretogranin-2,Chapter V Mental and behavioural disorders,KRA_PSY_MOOD_EXMORE,Wald ratio,1,1.38 [0.87-2.18],0.171715247114527,cis
SCG2,Secretogranin-2,Chapter I Certain infectious and parasitic diseases,AB1_BACT_BIR_OTHER_INF_AGENTS,Wald ratio,1,2.21 [0.68-7.15],0.185387964324538,cis
SCG2,Secretogranin-2,Chapter XII Diseases of the skin and subcutaneous tissue,L12_INFECT_SKIN_NAS,Wald ratio,1,0.4 [0.1-1.58],0.190486537232211,cis
SCG2,Secretogranin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,GOUT_NOS,Wald ratio,1,0.58 [0.25-1.32],0.192815606482893,cis
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,Wald ratio,1,1.43 [0.82-2.5],0.205515006423884,cis
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Wald ratio,1,0.66 [0.35-1.26],0.207714387543877,cis
SCG2,Secretogranin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_RHEUMA,Wald ratio,1,1.42 [0.82-2.48],0.211480048395228,cis
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,INFLUENZA,Wald ratio,1,0.59 [0.26-1.37],0.21845740184199,cis
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_CD_STRICT2,Wald ratio,1,0.4 [0.09-1.73],0.219072613086586,cis
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_CALCUKIDUR,Wald ratio,1,0.7 [0.38-1.29],0.248336864029766,cis
SCG2,Secretogranin-2,Chapter V Mental and behavioural disorders,F5_DEMINOTH,Wald ratio,1,0.36 [0.06-2.1],0.257922933355554,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,Wald ratio,1,1.15 [0.89-1.49],0.277078283417314,cis
SCG2,Secretogranin-2,Chapter XII Diseases of the skin and subcutaneous tissue,L12_ULCERLOWLIMB,Wald ratio,1,1.71 [0.64-4.55],0.280270274150443,cis
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,Wald ratio,1,1.85 [0.59-5.83],0.294414336314187,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Wald ratio,1,1.23 [0.82-1.83],0.310917569930276,cis
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,CHRONNAS,Wald ratio,1,0.5 [0.13-1.91],0.313051632881026,cis
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_VIRALPNEUMO,Wald ratio,1,1.68 [0.6-4.7],0.320051708933947,cis
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,Wald ratio,1,1.16 [0.87-1.54],0.321863332696412,cis
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_OTHGASTR,Wald ratio,1,1.42 [0.71-2.84],0.328081855283167,cis
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_RESPDISOTH,Wald ratio,1,0.75 [0.43-1.33],0.328670267250804,cis
SCG2,Secretogranin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIAINCHRONICDISEASE,Wald ratio,1,3.43 [0.29-40.69],0.329086698631869,cis
SCG2,Secretogranin-2,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_VIRAL_IMPL,Wald ratio,1,1.64 [0.6-4.5],0.333080377151168,cis
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,COLITNONINFNAS,Wald ratio,1,1.31 [0.76-2.24],0.333755919505316,cis
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_RESPIRATORY,Wald ratio,1,0.88 [0.67-1.15],0.348126961241317,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_HYPTENS,Wald ratio,1,1.12 [0.88-1.43],0.348228713622979,cis
SCG2,Secretogranin-2,Chapter XII Diseases of the skin and subcutaneous tissue,L12_CELLULITIS,Wald ratio,1,0.71 [0.34-1.47],0.354054807087081,cis
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_ASTHMA_EXMORE,Wald ratio,1,1.16 [0.84-1.59],0.370377591391552,cis
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,Wald ratio,1,1.59 [0.57-4.46],0.377712479562074,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_LBBB,Wald ratio,1,0.54 [0.14-2.15],0.385240117192035,cis
SCG2,Secretogranin-2,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_BACT_IMPL,Wald ratio,1,0.77 [0.43-1.41],0.402838829167335,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_CORATHER,Wald ratio,1,1.15 [0.82-1.61],0.408541273183011,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_ATHSCLE,Wald ratio,1,1.24 [0.74-2.07],0.414490343982261,cis
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,Wald ratio,1,0.57 [0.14-2.28],0.42874694303821,cis
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,Wald ratio,1,0.6 [0.17-2.15],0.435979770528619,cis
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,Wald ratio,1,0.46 [0.06-3.46],0.45238987704345,cis
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Wald ratio,1,0.64 [0.2-2.07],0.455303819879708,cis
SCG2,Secretogranin-2,Chapter I Certain infectious and parasitic diseases,AB1_INFECT_PARASIT,Wald ratio,1,1.13 [0.82-1.56],0.463997744343499,cis
SCG2,Secretogranin-2,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_CONDITION,Wald ratio,1,1.14 [0.8-1.64],0.471755673108184,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Wald ratio,1,1.18 [0.74-1.9],0.481349933917481,cis
SCG2,Secretogranin-2,Chapter I Certain infectious and parasitic diseases,AB1_GASTROENTERITIS_NOS,Wald ratio,1,0.88 [0.61-1.26],0.481378140352357,cis
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_GASTRODUOULC,Wald ratio,1,0.8 [0.43-1.51],0.497145627502858,cis
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_INTESTOTH,Wald ratio,1,1.09 [0.85-1.4],0.50019700431347,cis
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_LIVER,Wald ratio,1,0.83 [0.46-1.48],0.518695234155741,cis
SCG2,Secretogranin-2,Chapter XII Diseases of the skin and subcutaneous tissue,L12_INFECT_SKIN,Wald ratio,1,0.87 [0.57-1.33],0.527707071546443,cis
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_CD_NOUC,Wald ratio,1,0.58 [0.1-3.29],0.537388463864416,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,Wald ratio,1,0.52 [0.06-4.22],0.542509469364753,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_MI_STRICT,Wald ratio,1,1.14 [0.74-1.78],0.549219081480572,cis
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_OBSTRUREFLUROPATH,Wald ratio,1,0.74 [0.28-1.96],0.550620143364407,cis
SCG2,Secretogranin-2,Chapter XII Diseases of the skin and subcutaneous tissue,L12_OTHERSKINSUBCUTIS,Wald ratio,1,0.89 [0.6-1.32],0.556477022507256,cis
SCG2,Secretogranin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Wald ratio,1,0.82 [0.42-1.6],0.558677476930698,cis
SCG2,Secretogranin-2,Chapter VI Diseases of the nervous system,G6_PARKINSON,Wald ratio,1,1.31 [0.52-3.29],0.570501610623595,cis
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,Wald ratio,1,1.41 [0.41-4.85],0.589971141157096,cis
SCG2,Secretogranin-2,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACT_INOTHER,Wald ratio,1,2.7 [0.07-108.99],0.597789485119862,cis
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_HYDRONEPHR,Wald ratio,1,0.76 [0.26-2.17],0.603458450524745,cis
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Wald ratio,1,0.93 [0.72-1.22],0.610059729120901,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_CARDMYO,Wald ratio,1,0.82 [0.37-1.8],0.613713369906962,cis
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_PNEUMONAS,Wald ratio,1,1.13 [0.69-1.86],0.625565717854124,cis
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,Wald ratio,1,1.37 [0.38-4.97],0.635323299983466,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRLOW,Wald ratio,1,1.58 [0.24-10.61],0.63676369106773,cis
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_INFLUENZA,Wald ratio,1,0.86 [0.45-1.65],0.647320887336404,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,Wald ratio,1,1.15 [0.62-2.14],0.659315844380071,cis
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Wald ratio,1,0.55 [0.04-8.24],0.662255607252023,cis
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_TUBULOINTNEPHRNAS,Wald ratio,1,0.76 [0.21-2.78],0.674517312731437,cis
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_CHRONEPHROPATH,Wald ratio,1,1.46 [0.24-8.84],0.677791109725639,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_PAD,Wald ratio,1,1.21 [0.48-3.02],0.684478950788846,cis
SCG2,Secretogranin-2,Chapter VI Diseases of the nervous system,G6_POLYOTHUNS,Wald ratio,1,0.85 [0.38-1.9],0.685993969471936,cis
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Wald ratio,1,0.88 [0.47-1.63],0.686985810460528,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_HYPTENSPUL,Wald ratio,1,2.21 [0.05-107.77],0.68993104065275,cis
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_ACUTERENFAIL,Wald ratio,1,1.15 [0.52-2.52],0.727222975722671,cis
SCG2,Secretogranin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CATARACTOTHER,Wald ratio,1,0.92 [0.57-1.5],0.748252218013894,cis
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,Wald ratio,1,0.87 [0.38-2.03],0.752771301542381,cis
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_RECURANDPERHEAMATUR,Wald ratio,1,1.9 [0.03-108.04],0.75582050844672,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_HYPOTE,Wald ratio,1,1.15 [0.46-2.83],0.768052174404872,cis
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,Wald ratio,1,0.85 [0.27-2.7],0.780549151861644,cis
SCG2,Secretogranin-2,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_EXPLICIT,Wald ratio,1,0.92 [0.49-1.73],0.789101183386542,cis
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_GIDISEASES,Wald ratio,1,0.97 [0.77-1.22],0.789915752236824,cis
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Wald ratio,1,0.96 [0.69-1.33],0.797580491023426,cis
SCG2,Secretogranin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_OTHER_WIDE,Wald ratio,1,0.91 [0.42-1.96],0.807993012105151,cis
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2OPTH,Wald ratio,1,1.12 [0.44-2.87],0.811935080909439,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_VTE,Wald ratio,1,1.05 [0.68-1.64],0.813044843302953,cis
SCG2,Secretogranin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_NOS,Wald ratio,1,1.11 [0.43-2.92],0.824932370704989,cis
SCG2,Secretogranin-2,Chapter I Certain infectious and parasitic diseases,AB1_INTESTINAL_INFECTIONS,Wald ratio,1,0.97 [0.71-1.32],0.836647114594297,cis
SCG2,Secretogranin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_BCKGRND_RETINA,Wald ratio,1,0.87 [0.24-3.19],0.837622193300411,cis
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_GENITOURINARY,Wald ratio,1,0.97 [0.76-1.24],0.838841537897998,cis
SCG2,Secretogranin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_MACULOPATHY_EXMORE,Wald ratio,1,0.91 [0.33-2.5],0.85987057199647,cis
SCG2,Secretogranin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_THROMBOCYTOPENIANAS,Wald ratio,1,1.13 [0.28-4.48],0.863776794850866,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_CARDARR,Wald ratio,1,0.91 [0.25-3.34],0.882050933954004,cis
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,ASTHMA_NAS,Wald ratio,1,1.03 [0.67-1.59],0.882624821887382,cis
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_ACUTELOWERNAS,Wald ratio,1,0.94 [0.39-2.25],0.882744688205827,cis
SCG2,Secretogranin-2,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DECUBITANSULCERANDPRESSURE,Wald ratio,1,0.89 [0.19-4.21],0.884137560327557,cis
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_RENFAILNAS,Wald ratio,1,0.92 [0.28-3],0.890329196873768,cis
SCG2,Secretogranin-2,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Wald ratio,1,0.98 [0.72-1.33],0.89775144627888,cis
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_OTHENTERCOL,Wald ratio,1,1.04 [0.53-2.04],0.90500247701728,cis
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_UROLITHIASIS,Wald ratio,1,0.96 [0.45-2.03],0.908762573457246,cis
SCG2,Secretogranin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CHOROIDRETINA,Wald ratio,1,0.98 [0.69-1.4],0.918086176116469,cis
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_ENERCOLNONINF,Wald ratio,1,0.98 [0.61-1.55],0.91811721304206,cis
SCG2,Secretogranin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_MUSCULOSKELETAL,Wald ratio,1,1.01 [0.8-1.29],0.918270261506576,cis
SCG2,Secretogranin-2,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Wald ratio,1,1.03 [0.59-1.78],0.920172719436234,cis
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Wald ratio,1,0.91 [0.14-5.96],0.921617062276432,cis
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Wald ratio,1,0.98 [0.64-1.51],0.926800335331747,cis
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_KIDUROTH,Wald ratio,1,0.96 [0.35-2.62],0.930493979392399,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_OTHPER,Wald ratio,1,0.95 [0.27-3.36],0.936076928362998,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_OTHILLHEART,Wald ratio,1,1.06 [0.23-4.87],0.938514202574492,cis
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,Wald ratio,1,1.05 [0.22-5.04],0.948854916694808,cis
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_CROHN,Wald ratio,1,0.96 [0.22-4.24],0.958339270443249,cis
SCG2,Secretogranin-2,Chapter I Certain infectious and parasitic diseases,AB1_STREPTSTAPHYCOCC_INOTHER,Wald ratio,1,0.91 [0.01-118.56],0.971369353949962,cis
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_LOWCHRON,Wald ratio,1,1 [0.77-1.29],0.984078263554868,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_CHD,Wald ratio,1,1 [0.71-1.4],0.984218404263844,cis
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_NSTEMI,Wald ratio,1,0.99 [0.35-2.85],0.991366899520628,cis
SCG2,Secretogranin-2,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_IMPLICIT,Wald ratio,1,1 [0.65-1.53],0.999656401842147,cis
SCG2,Secretogranin-2,Chapter XII Diseases of the skin and subcutaneous tissue,L12_OTHERSKINSUBCUTIS,Inverse variance weighted,2,1.37 [1.08-1.74],0.00868437106280522,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_HYPTENS,Inverse variance weighted,2,0.85 [0.74-0.98],0.0288666160651847,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,Inverse variance weighted,2,0.84 [0.73-0.98],0.0306771612084117,trans
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_VIRALPNEUMO,Inverse variance weighted,2,1.92 [1.04-3.53],0.0357782003438375,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_LBBB,Inverse variance weighted,2,2.29 [1.02-5.16],0.0456471388587274,trans
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_RENFAILNAS,Inverse variance weighted,2,2.01 [1-4.05],0.0506721484495865,trans
SCG2,Secretogranin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CATARACTOTHER,Inverse variance weighted,2,1.33 [0.99-1.77],0.0550854108192599,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,Inverse variance weighted,2,1.42 [0.98-2.05],0.0627806106229896,trans
SCG2,Secretogranin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,2,1.34 [0.98-1.83],0.0681149960825782,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_OTHPER,Inverse variance weighted,2,0.5 [0.24-1.07],0.0733474619570865,trans
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_INTESTOTH,Inverse variance weighted,2,1.14 [0.98-1.32],0.0786231823924977,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Inverse variance weighted,2,1.38 [0.95-2],0.0909205909566178,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,Inverse variance weighted,2,0.23 [0.04-1.3],0.0962834192604902,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_CORATHER,Inverse variance weighted,2,1.18 [0.97-1.44],0.106463263763564,trans
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,Inverse variance weighted,2,1.59 [0.86-2.93],0.136271700788775,trans
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_OTHENTERCOL,Inverse variance weighted,2,1.35 [0.9-2.01],0.145522083669348,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_ARTOTH,Inverse variance weighted,2,1.65 [0.83-3.27],0.15279835131628,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,Inverse variance weighted,2,1.49 [0.85-2.6],0.161464572714437,trans
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_ENERCOLNONINF,Inverse variance weighted,2,1.22 [0.92-1.6],0.162783977119758,trans
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,2,1.14 [0.94-1.39],0.17876373058841,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_HYPOTE,Inverse variance weighted,2,1.44 [0.84-2.46],0.186402853596715,trans
SCG2,Secretogranin-2,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACT_INOTHER,Inverse variance weighted,2,0.24 [0.03-2.17],0.205344451215686,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,Inverse variance weighted,2,0.45 [0.13-1.55],0.206153584503637,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_RHEUVALV,Inverse variance weighted,2,0.43 [0.11-1.62],0.212246330305658,trans
SCG2,Secretogranin-2,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DECUBITANSULCERANDPRESSURE,Inverse variance weighted,2,1.85 [0.67-5.11],0.234680624069748,trans
SCG2,Secretogranin-2,Chapter I Certain infectious and parasitic diseases,AB1_GASTROENTERITIS_NOS,Inverse variance weighted,2,0.79 [0.53-1.18],0.248885642231136,trans
SCG2,Secretogranin-2,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Inverse variance weighted,2,1.14 [0.91-1.43],0.249486074134354,trans
SCG2,Secretogranin-2,Chapter VI Diseases of the nervous system,G6_POLYOTHUNS,Inverse variance weighted,2,0.76 [0.47-1.23],0.259050068949955,trans
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,Inverse variance weighted,2,2.4 [0.52-11.05],0.261256908650585,trans
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Inverse variance weighted,2,1.12 [0.92-1.35],0.268119568775413,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,Inverse variance weighted,2,0.68 [0.32-1.44],0.311010693371149,trans
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_INFLUENZA,Inverse variance weighted,2,1.22 [0.83-1.8],0.315644474541769,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Inverse variance weighted,2,2.28 [0.45-11.43],0.317357349670913,trans
SCG2,Secretogranin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_OTHER_WIDE,Inverse variance weighted,2,0.8 [0.51-1.26],0.331492236030277,trans
SCG2,Secretogranin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_MACULOPATHY_EXMORE,Inverse variance weighted,2,1.33 [0.73-2.41],0.350814821320504,trans
SCG2,Secretogranin-2,Chapter I Certain infectious and parasitic diseases,AB1_STREPTSTAPHYCOCC_INOTHER,Inverse variance weighted,2,0.26 [0.01-4.61],0.359649543459967,trans
SCG2,Secretogranin-2,Chapter I Certain infectious and parasitic diseases,AB1_INTESTINAL_INFECTIONS,Inverse variance weighted,2,0.88 [0.68-1.15],0.364595039700711,trans
SCG2,Secretogranin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,GOUT_NOS,Inverse variance weighted,2,1.25 [0.76-2.05],0.375526886941172,trans
SCG2,Secretogranin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CHOROIDRETINA,Inverse variance weighted,2,0.88 [0.66-1.17],0.380982565927112,trans
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_CD_STRICT2,Inverse variance weighted,2,2.34 [0.33-16.61],0.394534164433918,trans
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_KIDUROTH,Inverse variance weighted,2,0.78 [0.43-1.41],0.404992048674731,trans
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_TUBULOINTNEPHRNAS,Inverse variance weighted,2,0.72 [0.33-1.56],0.410686136619739,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,Inverse variance weighted,2,1.46 [0.58-3.71],0.421593130638119,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_CARDMYO,Inverse variance weighted,2,1.27 [0.71-2.27],0.42237487555376,trans
SCG2,Secretogranin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,2,0.85 [0.57-1.27],0.435895340796559,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_CARDARR,Inverse variance weighted,2,1.34 [0.62-2.9],0.460017492542737,trans
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Inverse variance weighted,2,1.37 [0.59-3.2],0.464479397510714,trans
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_LOWERINF,Inverse variance weighted,2,0.91 [0.71-1.17],0.474337062089758,trans
SCG2,Secretogranin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,2,1.14 [0.8-1.62],0.47758906447647,trans
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,INFLUENZA,Inverse variance weighted,2,1.19 [0.73-1.96],0.488383112553742,trans
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_ACUTELOWERNAS,Inverse variance weighted,2,0.83 [0.49-1.41],0.493760653791046,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,Inverse variance weighted,2,1.43 [0.49-4.14],0.512580228294684,trans
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_PLEUREFFUSION,Inverse variance weighted,2,0.84 [0.49-1.43],0.515223704077582,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRLOW,Inverse variance weighted,2,1.65 [0.36-7.59],0.519159283247438,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,Inverse variance weighted,2,0.8 [0.41-1.58],0.522505864216882,trans
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_RECURANDPERHEAMATUR,Inverse variance weighted,2,0.46 [0.04-5.09],0.527271856374672,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_OTHILLHEART,Inverse variance weighted,2,1.34 [0.54-3.3],0.531934238253659,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Inverse variance weighted,2,0.75 [0.31-1.83],0.533541536358497,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,Inverse variance weighted,2,0.76 [0.31-1.85],0.548310320742641,trans
SCG2,Secretogranin-2,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Inverse variance weighted,2,0.91 [0.65-1.26],0.557199951406343,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_VTE,Inverse variance weighted,2,0.9 [0.62-1.3],0.57776747182417,trans
SCG2,Secretogranin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_PURPURA_AND3_OTHER_HAEMORRHAGIC,Inverse variance weighted,2,0.83 [0.43-1.62],0.591998753984229,trans
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,CHRONNAS,Inverse variance weighted,2,1.4 [0.4-4.9],0.595026892783902,trans
SCG2,Secretogranin-2,Chapter VI Diseases of the nervous system,G6_PARKINSON,Inverse variance weighted,2,0.86 [0.5-1.5],0.603407717476109,trans
SCG2,Secretogranin-2,Chapter I Certain infectious and parasitic diseases,AB1_BACT_BIR_OTHER_INF_AGENTS,Inverse variance weighted,2,1.2 [0.6-2.41],0.607201787087816,trans
SCG2,Secretogranin-2,Chapter XII Diseases of the skin and subcutaneous tissue,L12_CELLULITIS,Inverse variance weighted,2,1.16 [0.64-2.1],0.616280051611565,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,Inverse variance weighted,2,1.3 [0.45-3.72],0.625080837878923,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,Inverse variance weighted,2,1.21 [0.56-2.6],0.628985690989356,trans
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_LOWCHRON,Inverse variance weighted,2,0.87 [0.51-1.51],0.62943132406533,trans
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_OTHGASTR,Inverse variance weighted,2,1.13 [0.67-1.9],0.643770678838275,trans
SCG2,Secretogranin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_NOS,Inverse variance weighted,2,1.14 [0.64-2.02],0.654619438094071,trans
SCG2,Secretogranin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_RHEUMA,Inverse variance weighted,2,0.93 [0.67-1.29],0.660636287096997,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,Inverse variance weighted,2,1.9 [0.1-34.72],0.663923153446853,trans
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_OESSTODUO,Inverse variance weighted,2,1.04 [0.86-1.26],0.673294113202839,trans
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_PLEURA,Inverse variance weighted,2,0.92 [0.61-1.38],0.674569956896889,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,Inverse variance weighted,2,0.84 [0.37-1.91],0.678028170026089,trans
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_ACUTERENFAIL,Inverse variance weighted,2,1.1 [0.69-1.76],0.678198824710692,trans
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,ASTHMA_NAS,Inverse variance weighted,2,0.92 [0.62-1.37],0.680906193071891,trans
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_CALCUKIDUR,Inverse variance weighted,2,0.86 [0.41-1.81],0.684084765286566,trans
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,Inverse variance weighted,2,0.96 [0.78-1.18],0.692445094046444,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_IHD,Inverse variance weighted,2,1.03 [0.87-1.23],0.708207887781386,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,Inverse variance weighted,2,1.11 [0.63-1.98],0.713853059018645,trans
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_ASTHMA_EXMORE,Inverse variance weighted,2,0.91 [0.53-1.54],0.714720347177463,trans
SCG2,Secretogranin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_THROMBOCYTOPENIANAS,Inverse variance weighted,2,0.86 [0.38-1.95],0.714954058267247,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,Inverse variance weighted,2,1.05 [0.79-1.41],0.735443241594592,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_HYPTENSPUL,Inverse variance weighted,2,1.43 [0.14-14.36],0.76364522770998,trans
SCG2,Secretogranin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,2,0.96 [0.76-1.22],0.765352933956935,trans
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,2,1.18 [0.39-3.6],0.770438051136444,trans
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,2,0.95 [0.66-1.36],0.770694723578711,trans
SCG2,Secretogranin-2,Chapter V Mental and behavioural disorders,F5_DEMINOTH,Inverse variance weighted,2,0.86 [0.28-2.63],0.79642696554931,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,2,1.04 [0.78-1.37],0.804790439063765,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_ATHSCLE,Inverse variance weighted,2,0.96 [0.71-1.31],0.807594017192275,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2OPTH,Inverse variance weighted,2,1.06 [0.61-1.86],0.82646445325613,trans
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_CHRONEPHROPATH,Inverse variance weighted,2,1.12 [0.39-3.25],0.83508418327543,trans
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_OBSTRUREFLUROPATH,Inverse variance weighted,2,0.95 [0.53-1.68],0.850983547466584,trans
SCG2,Secretogranin-2,Chapter XII Diseases of the skin and subcutaneous tissue,L12_INFECT_SKIN,Inverse variance weighted,2,1.05 [0.6-1.84],0.862434761462776,trans
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_GASTRODUOULC,Inverse variance weighted,2,0.97 [0.66-1.41],0.865216390532556,trans
SCG2,Secretogranin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIAINCHRONICDISEASE,Inverse variance weighted,2,0.89 [0.21-3.82],0.8717254085848,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,Inverse variance weighted,2,0.91 [0.28-2.97],0.877497912572844,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,Inverse variance weighted,2,0.97 [0.62-1.52],0.881238976962954,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_ANGINA,Inverse variance weighted,2,1.02 [0.81-1.27],0.886083500288366,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,Inverse variance weighted,2,0.97 [0.59-1.59],0.891803880895531,trans
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_DIAHER,Inverse variance weighted,2,1.03 [0.69-1.52],0.893596584041074,trans
SCG2,Secretogranin-2,Chapter XII Diseases of the skin and subcutaneous tissue,L12_ULCERLOWLIMB,Inverse variance weighted,2,1.04 [0.58-1.85],0.898970657132248,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_AF,Inverse variance weighted,2,1.02 [0.8-1.3],0.899786006862452,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,2,1.01 [0.8-1.29],0.908128378648254,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,Inverse variance weighted,2,1.05 [0.36-3.1],0.929858850843266,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,Inverse variance weighted,2,0.92 [0.05-15.69],0.95430691369648,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,Inverse variance weighted,2,1.01 [0.74-1.37],0.961996080158929,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_CHD,Inverse variance weighted,2,1 [0.82-1.23],0.978189823268526,trans
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_HYDRONEPHR,Inverse variance weighted,2,1.01 [0.51-1.99],0.983013110878081,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_MI_STRICT,Inverse variance weighted,2,1 [0.77-1.3],0.985238629999594,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Inverse variance weighted,2,1 [0.53-1.87],0.996380690796464,trans
